To include your compound in the COVID-19 Resource Center, submit it here.

BioAegis Therapeutics, Brigham and Women's Hospital deal

The hospital granted BioAegis an exclusive option to license worldwide rights to endogenous human

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE